Promoting Social-emotional Development and Self-esteem in Primary School Students
Launched by UNIVERSITEIT LEIDEN · Aug 24, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called "HiRO" aimed at helping primary school students, aged 4 to 13, improve their social-emotional skills, self-esteem, and how they feel about their classmates. The trial will compare schools using the HiRO program—either with or without judo classes—to schools that follow their usual approach to social-emotional development. Researchers want to find out if HiRO can make students more caring towards others, reduce feelings of anxiety and depression, boost self-esteem, and improve how students perceive their relationships with peers.
All primary school children are eligible to participate, and there are no specific exclusions. Participants will complete questionnaires at three different times to share their experiences and feelings about their social skills and emotional health. This study is an important step in understanding how effective the HiRO program is compared to regular school programs in supporting children’s emotional and social growth.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All primary school children
- Exclusion Criteria:
- • None
About Universiteit Leiden
Universiteit Leiden, a prestigious academic institution in the Netherlands, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and a commitment to ethical standards, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and public health, to drive impactful research initiatives. By fostering partnerships with healthcare professionals and industry stakeholders, Universiteit Leiden aims to contribute to the development of novel therapies and enhance clinical outcomes, ultimately benefiting patients and the broader scientific community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leiden, South Holland, Netherlands
Patients applied
Trial Officials
Bianca Boyer, PhD
Principal Investigator
Leiden University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported